Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Microb Cell Fact ; 14: 19, 2015 Feb 13.
Article in English | MEDLINE | ID: mdl-25889802

ABSTRACT

BACKGROUND: Antibodies raised against selected antigens over-expressed at the cell surface of malignant cells have been chemically conjugated to protein toxin domains to obtain immunotoxins (ITs) able to selectively kill cancer cells. Since latest generation immunotoxins are composed of a toxic domain genetically fused to antibody fragment(s) which confer on the IT target selective specificity, we rescued from the hydridoma 4KB128, a recombinant single-chain variable fragment (scFv) targeting CD22, a marker antigen expressed by B-lineage leukaemias and lymphomas. We constructed several ITs using two enzymatic toxins both able to block protein translation, one of bacterial origin (a truncated version of Pseudomonas exotoxin A, PE40) endowed with EF-2 ADP-ribosylation activity, the other being the plant ribosome-inactivating protein saporin, able to specifically depurinate 23/26/28S ribosomal RNA. PE40 was selected because it has been widely used for the construction of recombinant ITs that have already undergone evaluation in clinical trials. Saporin has also been evaluated clinically and has recently been expressed successfully at high levels in a Pichia pastoris expression system. The aim of the present study was to evaluate optimal microbial expression of various IT formats. RESULTS: An anti-CD22 scFv termed 4KB was obtained which showed the expected binding activity which was also internalized by CD22+ target cells and was also competed for by the parental monoclonal CD22 antibody. Several fusion constructs were designed and expressed either in E. coli or in Pichia pastoris and the resulting fusion proteins affinity-purified. Protein synthesis inhibition assays were performed on CD22+ human Daudi cells and showed that the selected ITs were active, having IC50 values (concentration inhibiting protein synthesis by 50% relative to controls) in the nanomolar range. CONCLUSIONS: We undertook a systematic comparison between the performance of the different fusion constructs, with respect to yields in E. coli or P. pastoris expression systems and also with regard to each constructs specific killing efficacy. Our results confirm that E. coli is the system of choice for the expression of recombinant fusion toxins of bacterial origin whereas we further demonstrate that saporin-based ITs are best expressed and recovered from P. pastoris cultures after yeast codon-usage optimization.


Subject(s)
ADP Ribose Transferases/metabolism , Bacterial Toxins/metabolism , Exotoxins/metabolism , Immunotoxins/metabolism , Recombinant Fusion Proteins/metabolism , Ribosome Inactivating Proteins, Type 1/metabolism , Single-Chain Antibodies/metabolism , Virulence Factors/metabolism , ADP Ribose Transferases/genetics , Bacterial Toxins/genetics , Blotting, Western , Burkitt Lymphoma/genetics , Burkitt Lymphoma/metabolism , Burkitt Lymphoma/pathology , Cell Line , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Escherichia coli/genetics , Escherichia coli/metabolism , Exotoxins/genetics , Humans , Immunotoxins/genetics , Pichia/genetics , Pichia/metabolism , Protein Biosynthesis/drug effects , Protein Biosynthesis/genetics , Recombinant Fusion Proteins/pharmacology , Ribosome Inactivating Proteins, Type 1/genetics , Saporins , Sialic Acid Binding Ig-like Lectin 2/immunology , Sialic Acid Binding Ig-like Lectin 2/metabolism , Single-Chain Antibodies/genetics , Single-Chain Antibodies/immunology , Virulence Factors/genetics , Pseudomonas aeruginosa Exotoxin A
2.
J Biol Chem ; 287(10): 7367-73, 2012 Mar 02.
Article in English | MEDLINE | ID: mdl-22228764

ABSTRACT

Members of the type 2 ribosome-inactivating proteins (RIPs) family (e.g. ricin, abrin) are potent cytotoxins showing a strong lethal activity toward eukaryotic cells. Type 2 RIPs contain two polypeptide chains (usually named A, for "activity", and B, for "binding") linked by a disulfide bond. The intoxication of the cell is a consequence of a reductive process in which the toxic domain is cleaved from the binding domain by oxidoreductases located in the lumen of the endoplasmic reticulum (ER). The best known example of type 2 RIPs is ricin. Protein disulfide isomerase (PDI) was demonstrated to be involved in the process of ricin reduction; however, when PDI is depleted from cell fraction preparations ricin reduction can still take place, indicating that also other oxidoreductases might be implicated in this process. We have investigated the role of TMX, a transmembrane thioredoxin-related protein member of the PDI family, in the cell intoxication operated by type 2 RIPs ricin and abrin. Overexpressing TMX in A549 cells resulted in a dramatic increase of ricin or abrin cytotoxicity compared with control mock-treated cells. Conversely, no difference in cytotoxicity was observed after treatment of A549 cells or control cells with saporin or Pseudomonas exotoxin A whose intracellular mechanism of activation is not dependent upon reduction (saporin) or only partially dependent upon it (Pseudomonas exotoxin A). Moreover, the silencing of TMX in the prostatic cell line DU145 reduced the sensitivity of the cells to ricin intoxication further confirming a role for this enzyme in intracellular ricin activation.


Subject(s)
Abrin/pharmacokinetics , Chemical Warfare Agents/pharmacokinetics , Endoplasmic Reticulum/metabolism , Membrane Proteins/metabolism , Ricin/pharmacokinetics , Thioredoxins/metabolism , ADP Ribose Transferases/pharmacokinetics , ADP Ribose Transferases/pharmacology , Abrin/pharmacology , Bacterial Toxins/pharmacokinetics , Bacterial Toxins/pharmacology , Chemical Warfare Agents/pharmacology , Endoplasmic Reticulum/genetics , Exotoxins/pharmacokinetics , Exotoxins/pharmacology , Humans , Jurkat Cells , Membrane Proteins/genetics , Oxidation-Reduction/drug effects , Protein Disulfide-Isomerases/genetics , Protein Disulfide-Isomerases/metabolism , Protein Synthesis Inhibitors/pharmacokinetics , Protein Synthesis Inhibitors/pharmacology , Ribosome Inactivating Proteins, Type 1/pharmacokinetics , Ribosome Inactivating Proteins, Type 1/pharmacology , Ricin/pharmacology , Saporins , Thioredoxins/genetics , Virulence Factors/pharmacokinetics , Virulence Factors/pharmacology , Pseudomonas aeruginosa Exotoxin A
SELECTION OF CITATIONS
SEARCH DETAIL
...